Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Nationally, 25% of patients admitted to the hospital from the emergency department have to wait 4 hours or more for a bed during nonpeak months.